A Partner in Diabetes Care: Henry Schein Medical Supports Health Care Professionals During Diabetes Awareness Month
Company Offers Essential Tools For Holistic Diabetes Management
MELVILLE, N.Y., November 5, 2024 – November marks American Diabetes Month®, a time to raise awareness of diabetes and to support the 1.2 million Americans diagnosed with diabetes each year, and more than 38 million Americans affected by the disease1. To help health care professionals enhance care and improve health outcomes for patients with diabetes, Henry Schein is offering its comprehensive range of diabetes management solutions.
Henry Schein Medical’s diabetes care offerings include capital equipment, point of care diagnostics, laboratory, hypodermic and blood collection, and pharmaceutical solutions, such as:
- Capital Equipment: Baxter RetinaVue700 Imager and Midmark steam sterilizers and chairs.
- Point of Care Diagnostics: Abbott Afinion™ 2 analyzer and Piccolo Xpress analyzers, HemoCue® Glucose 201 System and HemoCue® Hb 801 System, Henry Schein TRUE METRIX Pro Blood Glucose Meter Kit and OneStep+ Pro Hb Analyzer, PTS Diagnostics A1CNow and CardioChek® products, Siemens DCA Vantage analyzer, and Vidan Diagnostics Lucidplus™ B-Ketone Plus Blood Glucose Monitoring System.
- Laboratory: Beckman Coulter, Horiba, and Siemens chemistry and immunoassay analyzers. Tosoh Bioscience immunoassay analyzers, and Sysmex hematology analyzers.
- Hypodermics and Blood Collection: Embecta products and Sol-Millennium lancets.
- Pharmaceuticals: Over-the-Counter Medications and Rx.
“At Henry Schein, we recognize the integral role health care professionals play in helping patients manage diabetes, while offering guidance, resources, and treatment,” said Stephanie Shen, Chief Product Officer for Henry Schein’s North America Distribution Group. “To help practitioners effectively manage patients’ diabetes, Henry Schein provides access to a wide range of tools in a single place, from point-of-care diagnostics to remote patient monitoring. Together with our supplier partners, we are a trusted partner in helping practitioners enhance diabetes care.”
Also available through Henry Schein Medical is Rimidi. Its remote patient monitoring solution for diabetes connects patient-generated data from connected devices like blood glucose monitors, continuous glucose monitors, and insulin pens with clinical data in electronic health record (EHR) systems. This helps give clinicians a more complete view of a patient’s health and drives patient-specific clinical insights and actions within the framework of the latest evidence and guidelines. The platform lives within the EHR—integrating seamlessly into the provider workflow. Click here for a video from Dr. Lucienne Ide, Founder and CEO of Rimidi, who highlights three trends to watch in diabetes care.
In addition to its products and solutions, this year the Henry Schein Cares Foundation, Inc. (HSCF) launched Prevention is Power™, a multi-year public health awareness campaign aimed at supporting patient adoption of a preventive, integrated health care model to improve overall health outcomes. Part of the program is to provide health care practitioners with tools to advance understanding of the connection between oral health and overall health, with one of the focus areas being diabetes and oral health. Click here for more details about Prevention is Power.
For more information about Henry Schein Medical and its diabetes care products, click here.
1 American Diabetes Association. Diabetes By-the-Numbers. https://diabetes.org/.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 26,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.
For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.
CONTACT:
Lauren DelGuidice
Senior Corporate Media Relations Specialist
lauren.delguidice@henryschein.com
631.479.7309
###